7 research outputs found
Fragmentation processes of ionized 5-fluorouracil in the gas phase and within clusters
We have measured mass spectra for positive ions produced from neutral 5-fluorouracil by electron impact at energies from 0 to 100 eV. Fragment ion appearance energies of this (radio-)chemotherapy agent have been determined for the first time and we have identified several new fragment ions of low abundance. The main fragmentations are similar to uracil, involving HNCO loss and subsequent HCN loss, CO loss, or FCCO loss. The features adjacent to these prominent peaks in the mass spectra are attributed to tautomerization preceding the fragmentation and/or the loss of one or two additional hydrogen atoms. A few fragmentions are distinct for 5-fluorouracil compared to uracil, most notably the production of the reactive moiety CF+. Finally, multiphoton ionization mass spectra are compared for 5-fluorouracil from a laser thermal desorption source and from a supersonic expansion source. The detection of a new fragment ion at 114 u in the supersonic expansion experiments provides the first evidence for a clustering effect on the radiation response of 5-fluorouracil. By analogy with previous experiments and calculations on protonated uracil, this is assigned to NH3 loss from protonated 5-fluorouracil
Morphological and immunohistochemical peculiarities of oncomarkers in placental barrier
Histological and electron microscopy investigations in 47% cases showed disorders of microcirculation with haemorrage and excessive
deposits of extravillous fi brinoid with presence of pycnosis and nucleus polymorphism. In 1st investigation group in I pregnancy
trimester in placental barrier structures there were pronounced expression of proliferative marker (Ki-67), protein p53 and decrease
of these markers in III trimester that is proved by indexes of proliferation and it is caused by regulating infl uence of these factors on
the processes of growth, development, differentiation and cell death in placental barrier structures in pregnancy course. In 2nd group
pronounced Ki-67 expression in noted in cytotrophoblast nuclei and less pronounced - in stromal cells and endothelium of vesels that
is confi rmed by signifi cant increase of proliferative index. Expression of protein 53 was focal in nuclei of extravilleus trophoblast as
compared with negative one in control group. It was noted that oncofetal antigen in 1st group showed trace reaction in cytotrophoblast
in early terms of gestation (I trimester) and it was not determined in III trimester of pregnancy. In 2nd group in III trimester pronounced
immunoreactivity of oncofetal antigen in cytoplasm of stroma cellular elements (Hofbauer cells, fi broblasts) was noted. Pronounced
expression of fundamental marker of cell differentiation of cytokeratin in cyto- and syncytiotrophoblast in pregnancy course shows that
differentiation processes in placental barrier take place before term labor
Combined vaccines in the national prevention immunization schedules for the children in Belarus, Kazakhstan, Russia and Ukraine
Πhe announcement of the east European expert group for vaccine prevention presents position of the leading specialists of Russia, Belarus, Ukraine and Kazakhstan on key issues of the national pre vention immunization schedule. the authors examine in detail the aspects of vaccination against hepatitis type b, including optimal term of injection of the first vaccine dose, vaccination tactics for the premature and low weight newborns, safety of recombinant vaccines against hepatitis type Π². based on the analysis of the morbidity of h. influenzae type b invasive forms along with the methods recommended by who (HIB RAT), experts recommend introduction of the vaccine against this infection into the prevention immunization schedule. The experts believe the basis for the combined vaccines in pediatrics to be the vaccines with cellfree pertussis component. This class of vaccines allows introducing the additional booster dose of pertussis vaccines for immunization of the preschool children into the immunization schedule, which is dictated by the present epidemic situation with due account for this infection. The experts note the importance of application of the combined vaccines in pediatrics, whose wide implementation into healthcare system practices is in the interests of the parents, medical officers and society.Key words: hepatitis type Π², h. influenzae type b, HIB RAT, pertussis, diphteria and tetanus toxoids and pertussis vaccine, poliovaccines, combined vaccines, prevention immunization schedule, children
Combined vaccines in the national prevention immunization schedules for the children in Belarus, Kazakhstan, Russia and Ukraine
Πhe announcement of the east European expert group for vaccine prevention presents position of the leading specialists of Russia, Belarus, Ukraine and Kazakhstan on key issues of the national pre vention immunization schedule. the authors examine in detail the aspects of vaccination against hepatitis type b, including optimal term of injection of the first vaccine dose, vaccination tactics for the premature and low weight newborns, safety of recombinant vaccines against hepatitis type Π². based on the analysis of the morbidity of h. influenzae type b invasive forms along with the methods recommended by who (HIB RAT), experts recommend introduction of the vaccine against this infection into the prevention immunization schedule. The experts believe the basis for the combined vaccines in pediatrics to be the vaccines with cellfree pertussis component. This class of vaccines allows introducing the additional booster dose of pertussis vaccines for immunization of the preschool children into the immunization schedule, which is dictated by the present epidemic situation with due account for this infection. The experts note the importance of application of the combined vaccines in pediatrics, whose wide implementation into healthcare system practices is in the interests of the parents, medical officers and society.Key words: hepatitis type Π², h. influenzae type b, HIB RAT, pertussis, diphteria and tetanus toxoids and pertussis vaccine, poliovaccines, combined vaccines, prevention immunization schedule, children
ΠΠΠΠΠΠΠΠ ΠΠΠΠΠΠ«Π ΠΠΠΠ¦ΠΠΠ« Π ΠΠΠ¦ΠΠΠΠΠΠ¬ΠΠ«Π₯ ΠΠΠΠΠΠΠΠ Π―Π₯ ΠΠ ΠΠ€ΠΠΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ₯ ΠΠ ΠΠΠΠΠΠ ΠΠΠ― ΠΠΠ’ΠΠ Π ΠΠΠΠΠ Π£Π‘Π, ΠΠΠΠΠ₯Π‘Π’ΠΠΠ, Π ΠΠ‘Π‘ΠΠ Π Π£ΠΠ ΠΠΠΠ. ΠΠΠ―ΠΠΠΠΠΠ ΠΠ Π£ΠΠΠ« ΠΠΠ‘ΠΠΠ Π’ΠΠ Π ΠΠΠΠΠ‘Π’Π ΠΠΠΠ¦ΠΠΠΠΠ ΠΠ€ΠΠΠΠΠ’ΠΠΠ
Πhe announcement of the east European expert group for vaccine prevention presents position of the leading specialists of Russia, Belarus, Ukraine and Kazakhstan on key issues of the national pre vention immunization schedule. the authors examine in detail the aspects of vaccination against hepatitis type b, including optimal term of injection of the first vaccine dose, vaccination tactics for the premature and low weight newborns, safety of recombinant vaccines against hepatitis type Π². based on the analysis of the morbidity of h. influenzae type b invasive forms along with the methods recommended by who (HIB RAT), experts recommend introduction of the vaccine against this infection into the prevention immunization schedule. The experts believe the basis for the combined vaccines in pediatrics to be the vaccines with cellfree pertussis component. This class of vaccines allows introducing the additional booster dose of pertussis vaccines for immunization of the preschool children into the immunization schedule, which is dictated by the present epidemic situation with due account for this infection. The experts note the importance of application of the combined vaccines in pediatrics, whose wide implementation into healthcare system practices is in the interests of the parents, medical officers and society.Key words: hepatitis type Π², h. influenzae type b, HIB RAT, pertussis, diphteria and tetanus toxoids and pertussis vaccine, poliovaccines, combined vaccines, prevention immunization schedule, children.ΠΠ°ΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΠΎΡΡΠΎΡΠ½ΠΎ-ΠΠ²ΡΠΎΠΏΠ΅ΠΉΡΠΊΠΎΠΉ ΡΠΊΡΠΏΠ΅ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΏΠΎ Π²Π°ΠΊΡΠΈΠ½ΠΎΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΏΠΎΠ·ΠΈΡΠΈΡ Π²Π΅Π΄ΡΡΠΈΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ² Π ΠΎΡΡΠΈΠΈ, ΠΠ΅Π»Π°ΡΡΡΠΈ, Π£ΠΊΡΠ°ΠΈΠ½Ρ ΠΈ ΠΠ°Π·Π°Ρ
ΡΡΠ°Π½Π° ΠΏΠΎ ΠΊΠ»ΡΡΠ΅Π²ΡΠΌ Π²ΠΎΠΏΡΠΎΡΠ°ΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΊΠ°Π»Π΅Π½Π΄Π°ΡΠ΅ΠΉ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ²ΠΈΠ²ΠΎΠΊ. ΠΠΎΠ΄ΡΠΎΠ±Π½ΠΎ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ Π°ΡΠΏΠ΅ΠΊΡΡ Π²Π°ΠΊΡΠΈΠ½Π°ΡΠΈΠΈ ΠΏΡΠΎΡΠΈΠ² Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ β ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΡΠΉ ΡΡΠΎΠΊ Π²Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ΅ΡΠ²ΠΎΠΉ Π΄ΠΎΠ·Ρ Π²Π°ΠΊΡΠΈΠ½Ρ, ΡΠ°ΠΊΡΠΈΠΊΠ° Π²Π°ΠΊΡΠΈΠ½Π°ΡΠΈΠΈ Π½Π΅Π΄ΠΎΠ½ΠΎΡΠ΅Π½Π½ΡΡ
ΠΈ ΠΌΠ°Π»ΠΎΠ²Π΅ΡΠ½ΡΡ
Π΄Π΅ΡΠ΅ΠΉ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΡ
Π²Π°ΠΊΡΠΈΠ½ ΠΏΡΠΎΡΠΈΠ² Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ Π°Π½Π°Π»ΠΈΠ·Π° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ H. influenzae ΡΠΈΠΏΠ° b Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ², ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½Π½ΡΡ
ΠΠΠ (Hib-RAT), ΡΠΊΡΠΏΠ΅ΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΡΡΡ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ Π²Π°ΠΊΡΠΈΠ½Π°ΡΠΈΠΈ ΠΏΡΠΎΡΠΈΠ² ΡΡΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π² ΠΊΠ°Π»Π΅Π½Π΄Π°ΡΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ²ΠΈΠ²ΠΎΠΊ. ΠΡΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π²Π°ΠΊΡΠΈΠ½ Π² ΠΏΠ΅Π΄ΠΈΠ°ΡΡΠΈΠΈ ΡΠΊΡΠΏΠ΅ΡΡΡ ΡΡΠΈΡΠ°ΡΡ Π²Π°ΠΊΡΠΈΠ½Ρ Ρ Π±Π΅ΡΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌ ΠΊΠΎΠΊΠ»ΡΡΠ½ΡΠΌ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠΌ. ΠΠ°Π½Π½ΡΠΉ ΠΊΠ»Π°ΡΡ Π²Π°ΠΊΡΠΈΠ½ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ Π²Π²Π΅ΡΡΠΈ Π² ΠΊΠ°Π»Π΅Π½Π΄Π°ΡΡ ΠΏΡΠΈΠ²ΠΈΠ²ΠΎΠΊ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΡΠ΅Π²Π°ΠΊΡΠΈΠ½ΠΈΡΡΡΡΡΡ Π΄ΠΎΠ·Ρ ΠΊΠΎΠΊΠ»ΡΡΠ½ΠΎΠΉ Π²Π°ΠΊΡΠΈΠ½Ρ Π΄Π»Ρ ΠΈΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΠΈ Π΄ΠΎΡΠΊΠΎΠ»ΡΠ½ΠΈΠΊΠΎΠ², ΡΡΠΎ Π΄ΠΈΠΊΡΡΠ΅ΡΡΡ Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ°ΡΠΈΠ΅ΠΉ ΠΏΠΎ Π΄Π°Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. ΠΠΊΡΠΏΠ΅ΡΡΡ ΠΎΡΠΌΠ΅ΡΠ°ΡΡ ΡΠ΅Π½Π½ΠΎΡΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π²Π°ΠΊΡΠΈΠ½ Π² ΠΏΠ΅Π΄ΠΈΠ°ΡΡΠΈΠΈ, ΡΠΈΡΠΎΠΊΠΎΠ΅ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΡΠΎΡΡΡ
Π² ΠΏΡΠ°ΠΊΡΠΈΠΊΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ ΠΎΡΠ²Π΅ΡΠ°Π΅Ρ ΠΈΠ½ΡΠ΅ΡΠ΅ΡΠ°ΠΌ ΡΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ, ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΡΠ°Π±ΠΎΡΠ½ΠΈΠΊΠΎΠ² ΠΈ ΠΎΠ±ΡΠ΅ΡΡΠ²Π° Π² ΡΠ΅Π»ΠΎΠΌ. ΠΠ»ΡΡΠ΅Π²ΡΠ΅ ΡΠ»ΠΎΠ²Π°: Π³Π΅ΠΏΠ°ΡΠΈΡ Π, H. influenzae ΡΠΈΠΏΠ° B, Hib-RAT, ΠΊΠΎΠΊΠ»ΡΡ, ΠΠΠΠ‘, ΠΏΠΎΠ»ΠΈΠΎΠ²Π°ΠΊΡΠΈΠ½Ρ, ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Π²Π°ΠΊΡΠΈΠ½Ρ, ΠΊΠ°Π»Π΅Π½Π΄Π°ΡΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ²ΠΈΠ²ΠΎΠΊ, Π΄Π΅ΡΠΈ.(ΠΠ΅Π΄ΠΈΠ°ΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡ. β 2007; 4(1):6-18